Surrogate endpoint in advanced hepatocellular carcinoma treated with molecular targeted therapy: Meta-analysis of randomized controlled trials.

被引：0
|
作者：
Lee, Kyung-Hun
Lee, Dae-Won
Jang, Myoung-Jin
Kim, Tae-Yong
Han, Sae-Won
Oh, Do-Youn
Im, Seock-Ah
Kim, Tae-You
机构：
[1] Seoul Natl Univ Hosp, Seoul, South Korea
[2] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea
[3] Seoul Natl Univ Hosp, Internal Med, Seoul, South Korea
[4] Seoul Natl Univ Hosp, Dept Med, Seoul, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷 / 04期
关键词：
D O I：
10.1200/JCO.2017.35.4_suppl.454
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
454
引用
收藏
页数：1
相关论文
共 50 条
  • [21] THE EFFECT OF STATINS ON TESTOSTERONE: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS.
    Schooling, C. M.
    Yeung, S. L. Au
    Freeman, G.
    Cowling, B. J.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2012, 175 : S54 - S54
  • [22] Walking, lipids, and lipoproteins: A meta-analysis of randomized controlled trials.
    Kelley, GA
    Kelley, KS
    Tran, ZV
    CIRCULATION, 2004, 109 (07) : E108 - E109
  • [23] Transarterial chemoembolization for unresectable hepatocellular carcinoma:: Meta-analysis of randomized controlled trials
    Cammà, C
    Schepis, F
    Orlando, A
    Albanese, M
    Shahied, L
    Trevisani, F
    Andreone, P
    Craxì, A
    Cottone, M
    RADIOLOGY, 2002, 224 (01) : 47 - 54
  • [24] Safety profile of immune checkpoint inhibitors versus sorafenib as first-line treatment in advanced hepatocellular carcinoma: A meta-analysis of randomized controlled trials.
    Rizzo, Alessandro
    Frega, Giorgio
    Ricci, Angela Dalia
    Palloni, Andrea
    Tavolari, Simona
    Brandi, Giovanni
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
  • [25] Chemotherapy for advanced biliary tract carcinoma A meta-analysis of randomized controlled trials
    Chen, Lawrence
    Chen, Chiehfeng
    Yen, Yun
    Tam, Ka-Wai
    MEDICINE, 2016, 95 (33)
  • [26] Sorafenib improves the survival of patients with advanced hepatocellular carcinoma: a meta-analysis of randomized trials
    Zhang, Tao
    Ding, Xin
    Wei, Dong
    Cheng, Peng
    Su, Xiaomei
    Liu, Huanyi
    Wang, Daoyuan
    Gao, Hui
    ANTI-CANCER DRUGS, 2010, 21 (03) : 326 - 332
  • [27] Risk of hematological toxicities in patients with advanced breast cancer treated with everolimus: A meta-analysis of phase 3 randomized controlled trials.
    Sultan, Anita
    Thein, Kyaw Zin
    Swarup, Sriman
    D'Cunha, Ruth
    Hardwicke, Fred L.
    Jones, Catherine
    Awasthi, Sanjay
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [28] Efficacy and safety of frontline systemic therapy for advanced hepatocellular carcinoma (aHCC): A network meta-analysis of landmark phase III trials.
    Fulgenzi, Claudia A. M.
    Korolewicz, James
    D'Alessio, Antonio
    Scheiner, Bernhard
    Stikas, Charalampos-Vlasios
    Gennari, Alessandra
    Cortellini, Alessio
    Scotti, Lorenza
    Pinato, David J. James
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 549 - 549
  • [29] The Efficacy of Zoledronic Acid in Breast Cancer Adjuvant Therapy: A Meta-Analysis of Randomized Controlled Trials.
    Lu, J.
    Yan, T.
    Yin, W.
    Zhou, Q.
    Zhou, L.
    Jiang, Y.
    Du, Y.
    Shao, Z.
    CANCER RESEARCH, 2011, 71
  • [30] The Efficacy and Safety of Rituximab as Induction Therapy in Kidney Transplantation: A Meta-Analysis of Randomized Controlled Trials.
    Wang, X.
    Chen, J.
    Tu, X.
    Qiu, Y.
    Song, T.
    Lin, T.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 674 - 674
12345